Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (81-90 of 216) with videos related to

Pageof 22
Sort By:
Research and Practice in Thrombosis and Haemostasis|February 18, 2026
Factor VIII <i>in vitro</i> bioequivalence of denecimig (Mim8) hemostatic effect by thrombin generation assaysJacob Lund, Mirella Ezban, Kasper Jensen, et al.
Blood|April 23, 2017
Biological considerations of plasma-derived and recombinant factor VIII immunogenicityJesse Lai, Christine Hough, Julie Tarrant, et al.
Expert Review of Hematology|March 19, 2020
Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigmsDavid Lillicrap, Karin Fijnvandraat, Guy Young, et al.
Therapeutic Advances in Hematology|February 2, 2026
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expressionSylvia Fong, Laura L Swystun, Paul Batty, et al.
Cellular Immunology|December 18, 2015
War and peace: Factor VIII and the adaptive immune responseMaria T Georgescu, Jesse D Lai, Christine Hough, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2022
Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cellsChristine Hough, Colleen Notley, Aomei Mo, et al.
Cellular Immunology|November 9, 2015
To clear or to fear: An innate perspective on factor VIII immunityJesse Derek Lai, Maria Teofana Georgescu, Christine Hough, et al.
American Journal of Obstetrics and Gynecology|December 26, 2002
A survey of recommendations by gynecologists in Canada regarding oral contraceptive use in the perioperative periodJennifer Oakes, Philip M Hahn, David Lillicrap, et al.
Thrombosis and Haemostasis|August 28, 2002
A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assayBert Verbruggen, Waander van Heerde, Irena Novákovà, et al.
Journal of Molecular Modeling|August 24, 2004
Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutationsJeffrey J Sutherland, Lee A O'Brien, David Lillicrap, et al.
Pageof 22

Showing results (81-90 of 216) with videos related to

Sort By:
Pageof 22
Research and Practice in Thrombosis and Haemostasis|February 18, 2026
Factor VIII <i>in vitro</i> bioequivalence of denecimig (Mim8) hemostatic effect by thrombin generation assaysJacob Lund, Mirella Ezban, Kasper Jensen, et al.
Blood|April 23, 2017
Biological considerations of plasma-derived and recombinant factor VIII immunogenicityJesse Lai, Christine Hough, Julie Tarrant, et al.
Expert Review of Hematology|March 19, 2020
Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigmsDavid Lillicrap, Karin Fijnvandraat, Guy Young, et al.
Therapeutic Advances in Hematology|February 2, 2026
Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expressionSylvia Fong, Laura L Swystun, Paul Batty, et al.
Cellular Immunology|December 18, 2015
War and peace: Factor VIII and the adaptive immune responseMaria T Georgescu, Jesse D Lai, Christine Hough, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2022
Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cellsChristine Hough, Colleen Notley, Aomei Mo, et al.
Cellular Immunology|November 9, 2015
To clear or to fear: An innate perspective on factor VIII immunityJesse Derek Lai, Maria Teofana Georgescu, Christine Hough, et al.
American Journal of Obstetrics and Gynecology|December 26, 2002
A survey of recommendations by gynecologists in Canada regarding oral contraceptive use in the perioperative periodJennifer Oakes, Philip M Hahn, David Lillicrap, et al.
Thrombosis and Haemostasis|August 28, 2002
A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assayBert Verbruggen, Waander van Heerde, Irena Novákovà, et al.
Journal of Molecular Modeling|August 24, 2004
Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutationsJeffrey J Sutherland, Lee A O'Brien, David Lillicrap, et al.
Pageof 22